Imvanex Unione Europea - italiano - EMA (European Medicines Agency)

imvanex

bavarian nordic a/s - vaccinia modificata ankara - bavarian nordic (mva-bn) virus - smallpox vaccine; monkeypox virus - altri vaccini virali, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 e 5. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

Dengvaxia Unione Europea - italiano - EMA (European Medicines Agency)

dengvaxia

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vaccini - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 e 4. l'uso di dengvaxia dovrebbe essere in conformità con le raccomandazioni ufficiali.

Mvabea Unione Europea - italiano - EMA (European Medicines Agency)

mvabea

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - febbre emorragica di ebola - vaccini - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Ervebo Soluzione iniettabile Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ervebo soluzione iniettabile

msd merck sharp & dohme ag - rvsvdeltag-zebov-gp vivus attenuatum - soluzione iniettabile - rvsvdeltag-zebov-gp vivus attenuatum >7.2 mio u., trometamolum, albuminum humanum, aqua ad iniectabile, q.s. ad solutionem pro 1 ml. - ervebo ist indiziert für die aktive immunisierung von personen ab 18 jahren zum schutz vor der ebola-viruskrankheit (evd [ebola virus disease]), die durch das zaire-ebola-virus verursacht wird - vaccini

Nuvaxovid 0.5 ml Injektionsdispersion Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

nuvaxovid 0.5 ml injektionsdispersion

future health pharma gmbh - sars cov-2 rs nvx-cov2373 - injektionsdispersion - sars cov-2 rs nvx-cov2373 5 µg, adjuvans matrix-m: saponinum fraction-a 42.5 µg et saponinum fraction-c 7.5 µg ex quillaja saponariae molina extractum purificatum, cholesterolum, phosphatidylcholinum, int-rac-alpha-tocopherolum, kalii dihydrogenophosphas, kalii chloridum, dinatrii phosphas dihydricus, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, natrii chloridum, polysorbatum 80, natrii hydroxidum q.s. ad ph, acidum hydrochloridum q.s. ad ph, aqua ad iniectabile q.s. ad praeparationem pro 0.5 ml corresp., natrium 4.0 mg, kalium 0.003 mg. - aktive immunisierung zur vorbeugung der durch das sars-cov-2-virus verursachten coronavirus-2019-erkrankung (covid-19) ab 12 jahren - vaccini

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Unione Europea - italiano - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccini - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Qdenga Unione Europea - italiano - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaccini - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Spikevax Bivalent Original / Omicron 10 mg/ml Siringa preriempita Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spikevax bivalent original / omicron 10 mg/ml siringa preriempita

moderna switzerland gmbh - imelasomeranum, elasomeranum - siringa preriempita - suspension: imelasomeranum 0.025 mg pro dosi, elasomeranum 0.025 mg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas pro dosi, cholesterolum pro dosi, 1,2-distearoyl-sn-glycero-3-phosphocholinum pro dosi, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus pro dosi, trometamolum pro dosi, trometamoli hydrochloridum pro dosi, acidum aceticum pro dosi, natrii acetas trihydricus pro dosi, saccharum pro dosi, aqua ad iniectabile, pro dosi. - spikevax bivalent original / omicron ist für die aktive immunisierung zur vorbeugung der durch das sars-cov-2-virus verursachten coronavirus-2019-erkrankung (covid-19) bei personen ab 18 jahren indiziert. - vaccini

Abrysvo Unione Europea - italiano - EMA (European Medicines Agency)

abrysvo

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - infezioni da virus respiratorio sinciziale - vaccini - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. vedi sezioni 4. 2 e 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

LUPIDON G INIETT SC 4F 1ML Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

lupidon g iniett sc 4f 1ml

bruschettini srl - vaccino erpetico ii - preparazione iniettabile - "g sospensione iniettabile" 4 fiale 1 ml - other viral vaccines